Company intelligence / Profile preview

Asterion Cannabis

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Asterion developed one of the largest planned medicinal cannabis production facilities globally; their merger with ANTG in April 2021 created a major player in Australian cannabis with large-scale R&D, agricultural, and manufacturing capacity, but clinical/trial results are not published.

Therapeutic areas: OncologyImmunologyNeurologyPsychiatry
Modalities: Small molecule (cannabinoids, oils, tinctures, capsules)Biologic (potential future research; plant-derived biologics)
Industry: Biotech

Partnerships

PreveCeutical Medical Inc. (preventive medicine R&D)Queensland Alliance for Agriculture and Food Innovation (QAAFI), University of Queensland (agriculture/genetics R&D)White Sheep Corp (industry alliance)Pharmout (facility master planning)Wagner Corporation (site partner)Van der Hoeven (glasshouse supplier)

Beyond the preview

Go deeper on Asterion Cannabis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asterion Cannabis.

Explore the full profile